Another new drug has shown promising early results in improving survival for men with advanced prostate cancer. The newest drug showing positive results is called Alpharadin, made by Bayer. Alpharadin is the fourth drug in the past year designed to treat advanced prostate cancer that has shown good early results in improving survival.
Alpharadin, radium-223 chloride, is specifically designed to target prostate cancer which has invaded the bones.
A phase-III clinical trial analyzing Alpharadin showed that, when compared to placebo, there was an increased survival of 3 months in men with advanced prostate cancer. This trial was stopped prematurely due to the positive early results - researchers wanted to give those men randomly assigned to the placebo control group access to the real drug.
This is great news! It’s brilliant to see break throughs being talked about online. Break throughs like this bring so much hope to many patients.
Three months!!! All that work, all those animals sacrificed and yet they come up with only three months!! That is hardly a breakthrough in a real treatment. As a woman with a brother with prostate cancer, I’m terribly disappointed. Three months is three months but surely they can get onto a better track somehow.
iagree with Lois. three months is hardly worth calling a breakthrough. Lets get real. you need a better breakthrough that gives longer then 3 months
Good news, but limited benefit. I had a prostatectomy 10 years ago, than radiation and after the remaining cancer had spread to lymph glands, have contained PSA levels with Casodex and Buserelin acetate 9.9mg implants. It beats 3 months!